Latest filing published 20 Feb 2026 for OMEROS CORP, €3.6M.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +329.4%Entry US$1.80 · Close at T+365 US$7.73
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Gregory A. Demopulos MD: trading record in brief
All filings by Gregory A. Demopulos MD on record concern Omeros Corp, in the capacity of chief executive. Between 18 August 2011 and 18 February 2026, the trades on record add up to 45 filings.
In open-market terms, that means 1 purchase worth €23k on one side and 13 sales worth €9.4M on the other. Taken together, the sales exceed the purchases by €9.3M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 3 share grants and 25 option exercises.
Most recently, on 20 February 2026, the filings show a share grant worth €3.6M in Omeros Corp. The latest purchase dates back some time: it was published 1,083 days ago, on 21 November 2023. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Gregory A. Demopulos MD
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 357,678 shares@ US$11.9319.6% of flowCommon stockSEC:0001437749-26-004950:1
- 400,000 shares@ US$10.27100.0% of flowCommon stockSEC:0001437749-26-004950:0
- 300,000 shares0Common StockSEC:0001437749-25-031087:1
- 300,000 shares0Common StockSEC:0001437749-25-031087:2
- 600,000 shares0Common StockSEC:0001437749-25-031087:0
- 15,000 shares@ US$1.687.3% of flowCommon StockSEC:0001437749-23-032809:0Canonical exit: 15 Feb 2024 (T+90)
- 25,000 shares@ US$1.440.2% of flowCommon StockSEC:0001437749-23-032239:1
- 37,500 shares@ US$1.2914.3% of flowCommon StockSEC:0001437749-23-032239:0
- 36,856 shares@ US$15.023.1% of flowCommon StockSEC:0001415889-21-003077:1
- 36,857 shares@ US$4.100.9% of flowCommon StockSEC:0001415889-21-003077:2
- 36,857 shares@ US$14.903.1% of flowCommon StockSEC:0001415889-21-003077:3
- 36,856 shares@ US$4.1039.3% of flowCommon StockSEC:0001415889-21-003077:0
- 36,857 shares@ US$17.073.5% of flowCommon StockSEC:0001415889-21-002642:1
- 36,856 shares@ US$4.100.8% of flowCommon StockSEC:0001415889-21-002642:2
- 36,856 shares@ US$14.963.1% of flowCommon StockSEC:0001415889-21-002642:3
- 36,857 shares@ US$4.1039.1% of flowCommon StockSEC:0001415889-21-002642:0
- 37,407 shares@ US$4.100.9% of flowCommon StockSEC:0001415889-21-001949:0
- 37,407 shares@ US$17.913.8% of flowCommon StockSEC:0001415889-21-001949:1
- 35,206 shares@ US$4.100.8% of flowCommon StockSEC:0001415889-21-001949:2
- 35,206 shares@ US$17.763.6% of flowCommon StockSEC:0001415889-21-001949:3
- 102,040 shares@ US$2.451.9% of flowCommon StockSEC:0000899243-17-029690:0
- 39,961 shares@ US$4.101.2% of flowCommon StockSEC:0000899243-17-029690:1
- 102,040 shares@ US$0.980.8% of flowCommon StockSEC:0000899243-16-035087:0
- 102,040 shares@ US$10.7089.2% of flowCommon StockSEC:0000899243-16-035087:1
- 102,040 shares@ US$0.980.8% of flowCommon StockSEC:0000899243-16-035087:2
25 of 45 declarations
